MetLife, Inc. MET
100.67 USD +0.32 (+0.32%)
At closeNov 3, 2026, 4:57 PM EST
100.90 +0.23 +0.23%
After hours · Nov 3, 4:57 PM ET
99.28 Day range 101.29
67.33 52-week range 103.65
- YTD
- +27.53%
- 1 year
- +27.09%
Analyst view
Consensus: buy
Buy
Price target (mean) 107.63 +6.9% upside
Now 100.67
- Target (low)
- 84.00
- Target (mean)
- 107.63
- Target (high)
- 119.00
Ratings (0m) 18 13 buy · 4 hold · 1 sell
- Strong buy5
- Buy8
- Hold4
- Sell0
- Strong sell1
Recommendation trend
- This month 18
- 1 month ago 18
- 2 months ago 18
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.77 | 2.62 – 2.92 | 2.37 | +16.8% | 19.97B | +11.6% | 16 |
| Next quarter | 2.62 | 2.49 – 2.77 | 2.49 | +5.2% | 20.46B | -15.4% | 13 |
| Current year | 10.22 | 10.02 – 10.45 | 8.83 | +15.7% | 79.32B | +0.6% | 17 |
| Next year | 11.16 | 10.76 – 11.61 | 10.22 | +9.2% | 82.75B | +4.3% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 15, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 6, 2026 | UBS | Maintained | Buy | Buy |
| Oct 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| Sep 22, 2026 | Piper Sandler | Upgrade | Neutral | Overweight |
| Aug 24, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 19, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 11, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 21, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 13, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Jul 13, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 10, 2026 | Jefferies | Maintained | Buy | Buy |
| Jul 9, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| Jul 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 24, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| May 26, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| May 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 13, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| May 12, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2026 | Barclays | Maintained | Overweight | Overweight |
